Active Monitoring of the Comparative Effectiveness and Safety of Prasugrel vs. Clopidogrel in Routine Care

被引：0
|
作者：
Gagne, Joshua J. [1 ,2 ]
Rassen, Jeremy A. [1 ,2 ]
Choudhry, Niteesh K. [1 ,2 ]
Bohn, Rhonda L. [3 ]
Patrick, Amanda R. [1 ,2 ]
Sridhar, Gayathri [4 ]
Liu, Jun [1 ,2 ]
Schneeweiss, Sebastian [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Rhonda L Bohn LLC, Waban, MA USA
[4] HealthCore Inc, Govt & Acad Res, Wilmington, DE USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
508
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [21] MONITORING THE EFFECTIVENESS AND SAFETY OF ARNI VS. ANGIOTENSIN RECEPTOR BLOCKER BY FRAILTY STATUS
    Kim, Dae
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    INNOVATION IN AGING, 2021, 5 : 208 - 208
  • [22] Effectiveness and safety of empagliflozin in routine care patients: interim results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Bessette, L.
    Franklin, J.
    Najafzadeh, M.
    Wexler, D.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Schneeweiss, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S145 - S146
  • [23] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [24] Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Najafzadeh, Mehdi
    Bessette, Lily G.
    Zakoul, Heidi
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES, 2021, 70
  • [25] Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity
    Alexopoulos, D.
    Panagiotou, A.
    Xanthopoulou, I.
    Komninakis, D.
    Kassimis, G.
    Davlouros, P.
    Fourtounas, C.
    Goumenos, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) : 2379 - 2385
  • [26] Ticagrelor or prasugrel vs. clopidogrel in combination with anticoagulation for treatment of acute coronary syndrome in patients with atrial fibrillation
    Kirolos, Irene
    Ifedili, Ikechukwu
    Maturana, Miguel
    Premji, Alykhan Moez
    Cave, Brandon
    Roman, Sherif
    Jones, David
    Gaid, Romany
    Levine, Yehoshua C.
    Jha, Sunil
    Kabra, Rajesh
    Khouzam, Rami N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [27] Comparative Safety and Effectiveness of Heparin vs. Direct Oral Anticoagulants in Patients with Cirrhosis and ESKD
    Lohana, Abhi
    Akbar, Usman
    Muhibullah, Fnu
    Shafique, Nouman
    Shah, Syed Adil Mir
    Muddana, Neeharika
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [28] In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel
    Nanna, Michael G.
    Granger, Christopher B.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : JC44 - JC44
  • [29] Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
    Karasik, A.
    Lanzinger, S.
    Tan, E. Chia-Hui
    Yabe, D.
    JungKim, D.
    Sheu, W. H-H
    Melzer-Cohen, C.
    Holl, R. W.
    Ha, K.
    Nystrom, T.
    Niskanen, L.
    Jensen, M. Linnemann
    Kyaw, M. H.
    Nunez, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 229 - 230
  • [30] Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Karasik, Avraham
    Lanzinger, Stefanie
    Tan, Elise C. H.
    Yabe, Daisuke
    Kim, Dae Jung
    Sheu, Wayne H-H
    Cohen, Cheli Melzer
    Holl, Reinhard W.
    Ha, Kyoung Hwa
    Nystrom, Thomas
    Niskanen, Leo K.
    Jensen, Majken Linnemann
    Kyaw, Moe H.
    Nunez, Julio
    DIABETES, 2021, 70
12345